Ono Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Ono Pharmaceutical has a total shareholder equity of ¥783.3B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥895.9B and ¥112.6B respectively. Ono Pharmaceutical's EBIT is ¥166.8B making its interest coverage ratio -43.6. It has cash and short-term investments of ¥141.1B.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | -43.6x |
Cash | JP¥141.13b |
Equity | JP¥783.29b |
Total liabilities | JP¥112.63b |
Total assets | JP¥895.92b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4528 N's short term assets (¥355.3B) exceed its short term liabilities (¥101.0B).
Long Term Liabilities: 4528 N's short term assets (¥355.3B) exceed its long term liabilities (¥11.6B).
Debt to Equity History and Analysis
Debt Level: 4528 N is debt free.
Reducing Debt: 4528 N has no debt compared to 5 years ago when its debt to equity ratio was 0.1%.
Debt Coverage: 4528 N has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4528 N has no debt, therefore coverage of interest payments is not a concern.